LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.22
-0.02 (-0.28%)
Nov 20, 2024, 4:00 PM EST - Market closed
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for LFST stock have an average target of 8.42, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 16.62% from the current stock price of 7.22.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for LFST stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | -3.05% | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $9 → $7.5 | Hold | Maintains | $9 → $7.5 | +3.88% | Aug 15, 2024 |
| Barclays | Barclays | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | -16.90% | Aug 9, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $10 | Buy | Reiterates | $10 | +38.50% | Apr 22, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +24.65% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
1.25B
from 1.06B
Increased by 18.50%
Revenue Next Year
1.42B
from 1.25B
Increased by 13.19%
EPS This Year
-0.24
from -0.51
EPS Next Year
-0.18
from -0.24
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3B | 1.5B | 1.7B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.2B | 1.3B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.3% | 18.9% | 19.5% |
| Avg | 18.5% | 13.2% | 13.1% |
| Low | 13.2% | 7.2% | 6.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.18 | -0.11 | 0.01 |
| Avg | -0.24 | -0.18 | -0.10 |
| Low | -0.25 | -0.22 | -0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.